Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Uscom Limited ( (AU:UCM) ) just unveiled an announcement.
Uscom Limited reported net operating cash outflows of A$397,000 for the quarter ended 31 December 2025, with customer receipts of A$211,000 offset by continued spending on manufacturing, marketing, staff, and corporate costs, partly mitigated by A$464,000 in government grants and tax incentives. The company’s total cash burn for the half year reached A$1.29 million, while investing cash flows were negligible and financing activities included a short-term loan to related entity Uscom Australia Pty Ltd and lease repayments, resulting in a quarterly net cash outflow from financing of A$290,000, highlighting ongoing reliance on external support and careful cash management to sustain operations.
The most recent analyst rating on (AU:UCM) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Uscom Limited stock, see the AU:UCM Stock Forecast page.
More about Uscom Limited
Uscom Limited is an Australian-listed medical technology company focused on the development and commercialisation of non-invasive cardiovascular and pulmonary diagnostic devices, with products targeting global hospital and critical care markets.
Technical Sentiment Signal: Sell
Current Market Cap: A$3.12M
Learn more about UCM stock on TipRanks’ Stock Analysis page.